CASI - CASI Pharmaceuticals EPS misses by $0.08 beats on revenue November, 09 2020 07:14 AM CASI Pharmaceuticals Inc. CASI Pharmaceuticals (CASI): Q3 GAAP EPS of -$0.14 misses by $0.08.Revenue of $4.24M (+52.0% Y/Y) beats by $0.8M.Press Release For further details see: CASI Pharmaceuticals EPS misses by $0.08, beats on revenue